Search results
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Zacks via Yahoo Finance· 7 hours agoCharles River (CRL) and Captain T Cell announced an agreement on plasmid DNA and retrovirus vector...
Charles River and Captain T Cell sign vector production agreement
Pharmaceutical Technology via Yahoo Finance· 10 hours agoThe alliance is a strategic move for Captain T Cell as it prepares to manufacture a TCR-T cell ...
T-cell manufacturing: When is the right time to automate?
Pharmaceutical Technology via Yahoo Finance· 1 day agoAdvances in automation in T-cell production are beginning to help make life-changing therapies more...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
UPI· 5 days agoA study of more than 700 patients treated at Stanford University found that the risk of secondary...
CAR T cell therapy for advanced prostate cancer demonstrates positive results in Phase I clinical...
Medical Xpress· 6 days agoThe trial treated 14 prostate stem cell antigen (PSCA)-positive patients who had metastatic castration resistant prostate cancer (mCRPC), which had spread beyond the prostate ...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 6 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 7 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell...
APAC leaps ahead in adoptive cell therapy space
Pharmaceutical Technology via Yahoo Finance· 1 day agoHe also highlighted that overall, there are 1,023 single country adoptive cell therapy clinical studies being run in the APAC region compared to 476 in...
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 1 day agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...
Boosting CAR-T cell therapies from under the skin
Medical Xpress· 6 days agoOncological researchers suspect that disappointing treatment results can be the result of several circumstances, including poor quality of the CAR-T cell
